Outcome after surgical management of canine insulinoma in 49 cases
- PMID: 32558184
- DOI: 10.1111/vco.12628
Outcome after surgical management of canine insulinoma in 49 cases
Abstract
Canine insulinoma has historically been associated with a poor prognosis; however, prolonged survival times have recently been reported. Prognostic indicators that are available preoperatively are of limited predictive accuracy, and consensus on post-operative treatment recommendations is lacking. The objectives of this study were to describe outcomes in dogs with insulinoma treated surgically, and to assess whether selected potential risk factors are strongly associated with outcomes after surgery. Medical records of two institutions were searched for dogs with insulinoma that were treated surgically. Forty-nine dogs were included. Thirty-nine dogs (80%) had immediate resolution of hypoglycaemia and 10 (20%) remained persistently hypoglycaemic postoperatively. The median survival time (MST) for all dogs was 561 days. The MST for dogs that had resolution of hypoglycaemia was 746 days. The median of the overall euglycaemic time (times from surgery to first detection of hypoglycaemia at any time point after surgery) for all dogs was 424 days. Forty-four percent of those that had resolution of hypoglycaemia experienced recurrence of hypoglycaemia by 2 years postoperatively. Pathological stage was a predictor of persistent post-operative hypoglycaemia which, in turn, was a predictor of survival time. These results show that dogs with insulinoma can have prolonged survival, and that pathological stage is a predictor of outcome.
Keywords: insulinoma; metastasis; surgical oncology.
© 2020 John Wiley & Sons Ltd.
References
REFERENCES
-
- Goutal CM, Brugmann BL, Ryan KA. Insulinoma in dogs: a review. J Am Anim Hosp Assoc. 2012;48(3):151-163.
-
- Tobin RL, Nelson RW, Lucroy MD, Wooldridge JD, Feldman EC. Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990-1997). J Am Vet Med Assoc. 1999;215(2):226-230.
-
- Polton GA, White RN, Brearley MJ, Eastwood JM. Improved survival in a retrospective cohort of 28 dogs with insulinoma. J Small Anim Pract. 2007;48(3):151-156.
-
- Nelson RW. Beta-Cell Neoplasia: insulinoma. In: Feldman EC, Nelson RW, Reusch CE, Scott-Moncriefff JCR, eds. Canine and Feline Endocrinology. 4th ed. St. Louis MO: Elsevier; 2015:348-375.
-
- Northrup NC, Rassnick KM, Gieger TL, Kosarek CE, McFadden CW, Rosenberg MP. Prospective evaluation of biweekly streptozotocin in 19 dogs with insulinoma. J Vet Intern Med. 2013;27(3):483-490.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
